Truist Securities analyst Jake Bartlett maintains Wingstop (NASDAQ:WING) with a Buy and lowers the price target from $160 to $130.
JMP Securities Maintains Market Outperform on Vor Biopharma, Lowers Price Target to $12
JMP Securities analyst Silvan Tuerkcan maintains Vor Biopharma (NASDAQ:VOR) with a Market Outperform and lowers the price target from $15 to $12.